Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Routine home treatment of deep vein thrombosis.

× No keyword cloud information.

14 in total

Review 1. Antithrombotic therapy for venous thromboembolic disease.

Authors: T M Hyers; G Agnelli; R D Hull; T A Morris; M Samama; V Tapson; J G Weg
Journal: Chest Date: 2001-01 Impact factor: 9.410

2. Eligibility for home treatment of deep vein thrombosis: prospective study.

Authors: T Schwarz; B Schmidt; U Höhlein; J Beyer; H E Schröder; S M Schellong
Journal: BMJ Date: 2001-05-19

3. UK patients with deep-vein thrombosis can be safely treated as out-patients.

Authors: D O'Shaughnessy; J Miles; J Wimperis
Journal: QJM Date: 2000-10

4. Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group.

Authors: P Lindmarker; M Holmström
Journal: J Intern Med Date: 1996-12 Impact factor: 8.989

5. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.

Authors: L R Dolovich; J S Ginsberg; J D Douketis; A M Holbrook; G Cheah
Journal: Arch Intern Med Date: 2000-01-24

6. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study.

Authors: H Boccalon; A Elias; J J Chalé; A Cadène; S Gabriel
Journal: Arch Intern Med Date: 2000-06-26

7. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.

Authors: G Belcaro; A N Nicolaides; M R Cesarone; G Laurora; M T De Sanctis; L Incandela; A Barsotti; M Corsi; S Vasdekis; D Christopoulos; A Lennox; M Malouf
Journal: Angiology Date: 1999-10 Impact factor: 3.619

8. Low-molecular-weight heparin--an opportunity for home treatment of venous thrombosis.

Authors: A I Schafer
Journal: N Engl J Med Date: 1996-03-14 Impact factor: 91.245

9. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

Authors: M Levine; M Gent; J Hirsh; J Leclerc; D Anderson; J Weitz; J Ginsberg; A G Turpie; C Demers; M Kovacs
Journal: N Engl J Med Date: 1996-03-14 Impact factor: 91.245

10. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

Authors: M M Koopman; P Prandoni; F Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; M H Prins
Journal: N Engl J Med Date: 1996-03-14 Impact factor: 91.245

1 in total

1. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.

Authors: Thomas Wilke; Jörn Moock; Sabrina Müller; Matthias Pfannkuche; Andreas Kurth
Journal: Clin Orthop Relat Res Date: 2010-03-24 Impact factor: 4.176

1 in total